DRONEVER Trademark

Trademark Overview

On Monday, January 9, 2012, a trademark application was filed for DRONEVER with the United States Patent and Trademark Office. The USPTO has given the DRONEVER trademark a serial number of 85512073. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 1, 2019. This trademark is owned by Sanofi. The DRONEVER trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment of cardiovascular diseases
dronever

General Information

Serial Number85512073
Word MarkDRONEVER
Filing DateMonday, January 9, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 1, 2019
Registration Number4307596
Registration DateTuesday, March 26, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 8, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment of cardiovascular diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 1, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSanofi
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressParis 75008
FR
Party NameSanofi
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParis 75008
FR
Party NameSanofi
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParis 75008
FR

Trademark Events

Event DateEvent Description
Friday, November 1, 2019CANCELLED SEC. 8 (6-YR)
Monday, March 26, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 26, 2013REGISTERED-PRINCIPAL REGISTER
Wednesday, February 6, 2013CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Thursday, January 24, 2013ASSIGNED TO PETITION STAFF
Tuesday, January 8, 2013TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, January 8, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 8, 2013PUBLISHED FOR OPPOSITION
Wednesday, December 19, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 30, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 30, 2012ASSIGNED TO LIE
Wednesday, November 14, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 14, 2012NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, May 14, 2012LETTER OF SUSPENSION E-MAILED
Monday, May 14, 2012SUSPENSION LETTER WRITTEN
Wednesday, April 18, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 17, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 17, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 13, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 13, 2012NON-FINAL ACTION E-MAILED
Friday, April 13, 2012NON-FINAL ACTION WRITTEN
Friday, April 13, 2012ASSIGNED TO EXAMINER
Thursday, January 12, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 12, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

dronever cardiovascular diseases treatment human preparations pharmaceutical